Stimulation of the endometrium by estrogens without the differentiating effect of progestins is the primary etiological factor associated with the development of endometrial hyperplasia and adenocarcinoma. However, the correlation between sex steroids and gap junctional intercellular communication (GJIC), which is considered to play an important role in the control of cell growth and differentiation, is not well known in endometrial carcinoma. In this study, we focused on the influence of estrogen and its receptor in connexin (Cx) expression and GJIC in endometrial carcinoma cells, established stable clone IK-ER1 overexpressing ER-a to transfect the expression vector and analysed them in various hormonal conditions. The growth of IK-ER1 was accelerated by 17b-estradiol and the acceleration of the 5-bromo-25-deoxyuridine labeling index was observed. GJIC was assayed by scoring the number of dye-coupled cells after microinjecton of single cells with Lucifer-Yellow, and subcellular localization of Cx26 and Cx32 was analysed by immunocytochemistry. In the presence of estradiol, dyecoupled cells of IK-ER1 were significantly reduced compared to those without estradiol and the reduction was completely inhibited by adding ICI182.780, a pure antiestrogen substrate. Cxs were detected as only small spots by immunocytochemistry, and Western blotting showed that the expression was decreased. These results suggest that activation of ER-a by estrogen results in tumor progression by stimulating cell growth and suppressing GJIC via suppression of the expression of Cxs in endometrial carcinogenesis.
Introduction
Endometrial carcinoma is the most frequently diagnosed gynecological malignancy, and the incidence is increasing in industrial nations. It is well known that the functions of reproductive organs are regulated by the sex steroids and their receptors, estrogen receptor (ER) and progesterone receptor (PR), and it is hypothesized that the progression of carcinoma cells originating from the reproductive organs is influenced by them. Although it is widely accepted that endogenous and exogenous sources of unopposed estrogen increase the risk of endometrial adenocarcinoma, and several molecular alterations have been identified, the molecular pathogenesis of endometrial carcinoma remains poorly understood (Berchuck and Boyd, 1995) . Overexpression of the HER-2/neu oncogene (Lukes et al., 1994) and mutation of the K-ras oncogene (Sasaki et al., 1993) occur in 10-20% of endometrial adenocarcinomas. Mutation and overexpression of the p53 tumor suppressor gene (Lukes et al., 1994) and microsatellite instability (Duggan et al., 1994; Parc et al., 2000) have been detected in 20-30%. Mutation of the PTEN tumor suppressor gene occurs in 30-50% (Kong et al., 1997) . Mutation of exon 3 of the b-catenin gene was detected 10-46%, resulting in nuclear localization of b-catenin (Fukuchi et al., 1998; Nei et al., 1999) . However, how serum estrogen and ER affect the tumor progression is not well known.
Gap junctions are intercellular channels that directly connect the cytoplasm of the neighboring cells and allow exchanges of low molecular weight (less than about 1000 Da) metabolites, inorganic ions and other small hydrophilic molecules between the cells in contact. Second messengers in signal transduction such as cyclic AMP, Ca 2 þ and inositol trisphosphate can pass through gap junction channels. Therefore, gap junctional intercellular communication (GJIC) is considered to play an important role in the control of cell growth, differentiation, the maintenance of homeostasis and morphogenesis. The gap junction channels are composed of hexagonal arrangements of oligomeric proteins called connexins (Cxs) . It has been demonstrated that GJIC can be regulated by different factors, such as growth factors, oncogenes, Ca 2 þ , pH and hormones Huang et al., 2002; Klotz et al., 2002; Ozog et al., 2002) . Since carcinogenesis involves a disturbance of homeostasis and cancer cells show uncontrolled growth, it is considered that altered GJIC plays an important role in carcinogenesis (Trosko and Ruch, 1998) . Various lines of evidence suggest that a disturbance of GJIC facilitates the clonal growth of potential cancer cells and that Cx genes may act as tumor suppressors (Lee et al., 1992; Mesnil et al., 1995; Saito et al., 1998; Al Moustafa et al., 2002; Trosko and Ruch, 2002) . Several reports have demonstrated that Cx expression is decreased in precancerous lesions (Krutovskikh et al., 1991; Kamibayashi et al., 1995; Willecke et al., 1999) and mutated in some cancers (Saito et al., 1997a; Dubina et al., 2002) . Recently, we demonstrated that the expression of Cx26 and Cx32 was suppressed in the proliferative phase, in which serum estrogen was dominant, in the normal human endometrial epithelium (Saito et al., 1997b) , and expression in most endometrial hyperplasia and carcinoma samples was suppressed, indicating that, during endometrial carcinogenesis, loss of GJIC may occur in relatively early stages . It is thus of interest to examine whether the estrogen stimulation suppresses GIIC in endometrial carcinoma cells. We therefore established stable clones overexpressing ER-a to transfect the expression vector and analysed the influence on GJIC in various hormonal conditions.
Materials and methods

Cell line
Human endometrial cancer cell line Ishikawa, which expresses ER and PR (Nishida, 2002) , was used in this study. Cells were grown in minimum essential medium (MEM) without phenol red (Gibco BRL, Rockville, MD, USA) supplemented with 10% dextran-coated, charcoal-stripped fetal bovine serum (C-FCS).
Transfection of ER-a cDNA
Half-confluent cultures of Ishikawa cells were cotransfected with 2 mg of HEGO containing human ER-a cDNA (Tora et al., 1989) and 0.2 mg of PSV2-neo containing a G418-resistant gene (Southern and Berg, 1982) using Lipofectin (Gibco-BRL), according to the manufacturer's protocol. After 48 h, medium was replaced and G418 (Sigma Chemical Co., St Louis, MO, USA) was added to select resistant clones.
All of the subsequent experiments used the ER-overexpressing clones Ishikawa (IK-ER1), a control-transfected clone (IK-neo) and original Ishikawa (IK-wild). To develop a cell line overexpressing ER-a, we cotransfected cells with a G-418 resistance-conferring plasmid and an ER-a-expressing vector. The ER-overexpressing clones were selected for G-418 resistance and then screened for the existence of the ER-aexpressing vector by PCR. The efficiency of the ER-aexpressing vector, HEGO, was confirmed in a previous work , and the expression of ER-a was confirmed by Western blotting. The expression of ER-a in IK-ER1 was 10.3 times larger than that of IK-neo (data not shown). We also analysed the mRNA expression of PR, which is known as one of the parameters of ER activity (Jamil et al., 1991) , and PR expression was markedly accelerated in IK-ER1 compared to IK-neo.
Cell proliferation study
We analysed the cell growth until 120 h after exposure to E2. On the second day, the medium was replaced with fresh medium containing 10 À8 mol/l E2 or without E2. For cell growth experiments, cells were plated at 1 Â 10 4 cells/60-mm dish in MEM containing 10% C-FCS. Fresh medium was added every day and cells were counted at 0, 24, 48, 72, 96 and 120 h after changing the medium. Each experiment was carried out in triplicate.
Estimation of GJIC by dye-transfer assay IK-wild, IK-neo and IK-ER1 were cultured with 10 À8 mol/l E2 (E( þ )) and 10 À8 E2 plus 10 À6 ICI182.780 (AstraZeneca Pharmaceuticals, Wilmington, DE, USA) (ICI) or without E2 (E(À)) for 48 h. GJIC was assayed by scoring the number of dye-coupled cells after microinjecton of single cells with Lucifer-Yellow (Sigma Chemical Co., St Louis, MO, USA) using an Olympus Injectoscope IMT-2 SYF and Eppendorf pressure injection system as described previously (Saito et al., 1998) . The extent of GJIC was determined by the number of fluorescent neighboring cells, scored with the aid of a fluorescence/phase-contrast microscope 1 min after injection. For each experimental point, 10-20 independent injections were carried out.
BrdU labeling index
To examine the labeling index, immunocytochemical staining for 5-bromo-2 0 -deoxyuridine (BrdU) was carried out. IK-wild, IK-neo and IK-ER1 were cultured with 10 À8 mol/l E2 and 10
À8
E2 plus 10
À6
ICI182.780 (AstraZeneca Pharmaceuticals, Wilmington, DE, USA) or without E2 for 48 h. In total, 20 mmol of BrdU was added to each 35-mm dish 24 h before fixation, after which the cells were fixed in cold absolute ethanol. A mouse anti-BrdU antibody (Dakopatts, Copenhagen, Denmark) was used as the primary antibody, followed by application of the ABC method (Vectain ABC Elite kit, Vector Laboratory, Burlingame, CA, USA). Labeled cells that had nuclei stained for BrdU were counted using a microscope (magnification Â 200). More than 1000 cells were counted per dish and three dishes were examined per experiment.
Immunofluorescence
The cultured cells on chamber slides (Lab-Tek chamber slides, Nalge Nunc International, Naperville, IL, USA) were fixed with cold acetone. The fixed tissue cells were preincubated with a blocking solution (PBS containing 5% skimmed milk) for 30 min at room temperature incubated with anti-Cx26 (Clone No., CX-12H10, Zymed Laboratories Inc.) diluted 1 : 500 and anti-Cx32 (Clone No., CX-2C2; Zymed Laboratories Inc.) diluted 1 : 500 for 2 h, and washed in PBS. FITC-conjugated anti-mouse immunogloblin diluted 1 : 100 in PBS was then added (Dakopatts, Copenhagen, Denmark) and the slides were incubated for 1 h. After incubation with secondary antibodies, the slides were washed in PBS, mounted in fluorescent mounting medium (Dakopatts) and examined by immunofluorescent microscopy (Nikon, Tokyo).
For double staining of BrdU and Cx26, the cells grown on chamber slides and treated with 20 mmol of BrdU were fixed with cold acetone. Polyclonal anti-Cx26 (Zymed Laboratories Inc.) diluted 1 : 200 and monoclonal anti-BrdU (Dakopatts) antibodies were used as primary antibodies. The secondary antibodies used were FITC-conjugated anti-mouse immunogloblin (Dakopatts) for BrdU staining and rhodamineconjugated anti-rabbit immunogloblin (Dakopatts) for Cx26 staining.
Western blotting of Cx26 and 32
IK-ER1, IK-neo and IK-wild were cultured with 10 À8 mol/l E2, 10 À8 E2 plus 10 À6 ICI182.780 (AstraZeneca Pharmaceuticals) or without E2 for 48 h. Then cells were collected using a cell Suppressed GJIC by estrogen in endometrial carcinoma T Saito et al scraper. Each sample was mixed with SDS electrophoresis sample buffer (10 mmol/l Tris-HCl, pH 7.8, 1 mmol/l EDTA, 3% sodium dodecyl sulfate, 5% glycerol, 10% mercaptoethanol), heated for 5 min at 95 o C, run on 9% polyacrylamide electrophoresis gels (Mini-Protein II, Bio-Rad), and then blotted onto a polyvinylidene difluoride membrane (Bio-Rad, CA, USA). The filters were blocked in 5% (w/v) dry milk in PBS containing 0.05% Tween 20 (T-PBS) and incubated for 2 h at room temperature in anti-Cx26 or -Cx32 (Zymed Laboratories, Inc., San Francisco, CA, USA) diluted 1 : 500 in PBS. After four washes with 0.05% T-PBS, the blots were incubated for 1 h at room temperature with a horseradishperoxidase anti-mouse antibody (Dakopatts Glostrop, Denmark) diluted 1 : 1000 in 5% (w/v) with dry milk in T-PBS. They were then washed and treated with enhanced chemiluminescence Western blotting detection reagents (Amersham, Little Chalfont, Bucks) and exposed to blue-light-sensitive autoradiographic film (Hyperfilm-ECL, Amersham). In negative controls, normal mouse serum was used as the first antibody. The densities of the positive bands were measured using NIH Image.
Statistical analysis
Analysis of variance and Student's t-test were used to determine the statistical significance of differences between control and treatment groups.
Results
Effect of overexpression of ER-a on cell growth and BrdU labeling index
Using IK-ER1, IK-neo and IK-wild, we analysed the cell growth at 24, 48, 72, 96 and 120 h after exposure to E2. On the second day, the medium was replaced with fresh medium containing 10 À8 mol/l E2 or without E2 (control). As shown in Figure 1 , the growth of IK-neo and IK-wild was not different between cells with 10 À8 mol/l E2 and the control until 96 h, and was significantly higher in 10 À8 mol/l E2 than in the control medium at 120 h. On the other hand, although growth of IK-ER1 did not show any significant difference between 10 À8 mol/l E2 and the control medium at 24 h, it was clearly higher in the medium with 10 À8 mol/l E2 than in the control medium at 48 h and later.
The BrdU labeling index showed a result similar to the cell growth curve (Figure 2 ). For IK-wild and IKneo, the labeling index was slightly elevated, but not significantly, in E( þ ) conditions. On the other hand, that of IK-ER1 was significantly elevated in E( þ ) conditions and the elevation by E2 was inhibited by ICI182.780, a pure antiestrogen substrate.
Estimation of GJIC by dye-transfer assay and subcellular localization of Cx26 and Cx32 with or without estradiol GJIC was assayed by scoring the number of dye-coupled cells after microinjecton of single cells with LuciferYellow, and subcellular localization of Cx26 and Cx32 was analysed by immunocytochemistry for the cultured endometrial carcinoma cells. For the assay, IK-wild, IKneo and IK-ER1 were cultured under E( þ ), ICI or E(À) conditions for 48 h.
As shown in Figure 3 , IK-wild showed 45.078.0 of dye-coupled cells after microinjecton of single cells in the E(À) condition. In the E( þ ) condition, although it Figure 1 Effect of overexpression of ER-a on cell growth. On the second day after plating, the medium was replaced with fresh medium containing 10 À8 mol/l E2 or without E2 (control). The growth of IK-neo and IK-wild was not different between cells with 10 À8 mol/l E2 and the control until 96 h, and was significantly higher with 10 À8 mol/L E2 than in the control medium at 120 h. On the other hand, the growth of IK-ER1 was clearly higher in the medium with 10 À8 mol/l E2 than in the control medium at 48 h and later Figure 2 Changes of BrdU labeling index in conditions with/ without estradiol. For IK-wild and IK-neo, the BrdU labeling index was slightly, but not significantly, elevated in the E( þ ) medium. On the other hand, that of IK-ER1 was significantly elevated in E( þ ) and the elevation by E2 was inhibited by ICI182.780, a pure antiestrogen substrate. *Po0.05
Suppressed GJIC by estrogen in endometrial carcinoma T Saito et al was slightly decreased (37.175.2), the difference was not significant. IK-neo showed the same result as IK-wild, whereas, IK-ER1 showed drastic changes in these estrogen conditions. For E(À) (Figure 4a and d) , IK-ER1 showed 36.277.2 of dye-coupled cells but this was significantly reduced to 18.972.5 for E( þ ) (Figure 4b and e), and the reduction was completely inhibited by adding 10 À6 ICI182.780 (39.476.9, Figure 4c and f). Immunohistochemical findings were correlated with the results of the dyetransfer assays. For E(À), Cx26 was localized on cellcell border as a patchy structure (Figure 4g ). For E( þ ), although some small spots were observed (Figure 4h ), the structures of gap junctions were obviously smaller than that for E(À). However, after adding 10 À6 ICI182.780, the size of positive staining of Cx26 was the same as for E(À) condition (Figure 4i ). Cx32 showed same changes as Cx26 by immunocytochemistry (data not shown).
Western blotting of Cx26 and 32 with or without estradiol
The expression of Cx26 and Cx32 in E( þ ), ICI and E(À) conditions in IK-ER1 was analysed by Western blotting. For the assay, IK-ER1, IK-neo and IK-wild were cultured with 10 À8 mol/l E2 (E( þ )), 10 À8 E2 plus 10 À6 ICI182.780 (ICI) or without E2 (E(À)) for 48 h. IKwild and IK-neo did not show clear changes in conditions of E(À), E( þ ) and ICI. On the other hand, in IK-EI1 E( þ ), the expression of Cx26 was decreased to 0.29 times that of in E(À) (Figure 5 ). The expression of Cx32 in E( þ ) was also reduced to 0.31 times of E(À). However, the reductions of expression by E( þ )were inhibited by adding 10 À6 ICI182.780 for both Cx26 and Cx32.
BrdU labeling and immunohistochemical findings for Cx26
To study the relationship between Cx26 expression and DNA synthesis stimulated by estradiol, double staining of BrdU and Cx26 was performed using IK-ER1. IK-ER1 cells were cultured in E(À), E( þ ) and ICI conditions for 48 h, and 20 mmol of BrdU was added to the cells 24 h before fixation. For E(À), as shown in Figure 1 , IK-ER1 did not have many BrdU labeled cells (Figure 6a) , and these cells expressed Cx26 as patchy structures on the cell-cell borders (Figure 6b) . For E( þ ), BrdU-labeled cells increased (Figure 6c ) but Cx26 was not detected in these cells (Figure 6d ). For ICI, the result was identical to that for E(À) (data not shown).
Discussion
Since carcinogenesis involves a disturbance of homeostasis and cancer cells show uncontrolled growth, it is considered that altered GJIC play important roles in it. Several lines of evidence suggest that a disturbance of GJIC facilitates the clonal growth of potential cancer cells and that Cx genes may act as tumor suppressors (Zhu et al., 1991; Lee et al., 1992; Mesnil et al., 1995; Trosko and Chang, 2001) . Several reports demonstrated that Cx expression was decreased in precancerous lesions. For example, in our previous study, preneoplastic and neoplastic lesions such as endometrial hyperplasia and carcinoma showed obvious decreases in levels of Cx26 and Cx32 mRNA, and immunohistochemically aberrant localization . Recently, several studies demonstrated that hypermethylation in the promoter region was a mechanism for the Cx32 gene repression (Singal et al., 2000; Tan et al., 2002; Hirai et al., 2003) , although it was not found in other tumors (Loncarek et al., 2003) . However, little is known about the mechanism decreasing GJIC in the endometrium. In the present study, we analysed the correlation between excess estrogen stimulation and GJIC in endometrial carcinoma cell line Ishikawa.
It has also been shown that gap junction populations in various female reproductive organs change significantly during hormone-dependent events (Heikaus et al., 2002) . For example, the preovulatory ovarian follicle contains a large population of gap junctions that connect granulosa cells to each other and to the oocyte in rats (Risek et al., 1990) ; during pregnancy and menstruation, the gap junction or the gap junction protein (Cx43) in rat myometrium changes drastically (Petrocelli and Lye, 1993; Risek et al., 1995) . The expression of Cx26 and Cx32 in endometrial epithelium in rats was reported to be regulated by ovarian steroid hormones, especially progesterone (Risek et al., 1995; Grummer et al., 1999) , and we have reported changes in Cxs in the human endometrium during the reproductive cycle (Saito et al., 1997b) . However, the correlation between estrogen and GJIC in vitro has not been sufficiently elucidated. . In E( þ ), although it was slightly decreased (37.175.2), the difference was not significant. IK-neo showed the same result as IK-wild, whereas IK-ER1 showed a drastic change in these estrogen conditions. For E(À), IK-ER1 showed 36.277.2 of dye-coupled cells but it was significantly reduced to 18.972.5 for E( þ ), and the reduction was completely inhibited by adding 10 À6 ICI182.780 (39.476.9). *Po0.05
Suppressed GJIC by estrogen in endometrial carcinoma T Saito et al In this study, we transfected an ER-a-expressing vector into endometrial carcinoma cell line Ishikawa (Nishida, 2002) , which expresses ER and PR and responds to estrogen and progesterone stimulation, and established an ER-overexpressing clone to clarify the effect of estrogen. The reason we selected Ishikawa for this experiment was that it has various signaling pathways responding to ER, and is one of the rare endometrial cell lines that have GJIC (Nishimura et al., 2003) . We also transfected the ER-a-expressing vector into other endometrial carcinoma cell lines, HEC-1BE and SNG-M, which do not express ER, but we could not find any growth acceleration by estradiol, possibly because these cells had lost not only ER but also cofactors (Thenot et al., 1999; Mizumoto et al., 2002) .
In medium containing estradiol, the growth of IK-ER1 was clearly accelerated compared to control cell lines IK-wild and IK-neo. This suggested that the transfected ER-a genes stimulated cell proliferation when exposed to estradiol. This was supported by the finding that the BrdU labeling index was accelerated in E( þ ) IK-ER1 in E( þ ). On the other hand, Ali et al. (2000) recently demonstrated that ER-a-mediated in vivo growth inhibition of tumors xenografted from ERtransfected Ishikawa cells and inhibition of VEGF and other angiogenic parameters in the cells. Their results were completely different from those of other studies using wild-type-Ishikawa cells (Holinka et al., 1986; Anzai et al., 1992; Kleinman et al., 1995; Darnel et al., 1999) and from ours. This may have been because their experiments and ours used different methods to evaluate the ER-a-expressing vectors; they evaluated in vivo and we in vitro, and a high level of ER may be cytotoxic.
Unopposed estrogen is the strongest risk factor associated with endometrial cancer. Although little is known about the molecular events involved, a close Figure 4 Lucifer-Yellow dye-transfer assay and immunocytochemical findings for Cx26 in IK-ER1 with/without estradiol. Immunocytochemical findings were correlated with the results of dye-transfer assays. For E(À), IK-ER1 communicated well (a and d) and Cx26 is localized on cell-cell border as a patchy structure (g). For E( þ ), GJIC was decreased (b and e) and although some small spots were observed (h), the structures of gap junctions were obviously smaller than that for E(À). However, with adding of 10 Suppressed GJIC by estrogen in endometrial carcinoma T Saito et al relationship has been observed between estrogenic stimulation of the endometrium and the appearance of endometrial hyperplasia . In fact, almost all of the hyperplasia samples had ER in the nuclei (Wataba et al., 2001) . There is evidence that the expression of molecules that are stimulated by ER is enhanced in endometrial hyperplasia (Saito et al., 1997c; Nei et al., 1999; Wataba et al., 2001; Ashihara et al., 2002) . Endometrial hyperplasias constitute a spectrum from simple to complex to atypical regions. It is estimated that the incidences of progression to malignancy from simple, complex and atypical regions are from 1 to 5, 5 to 10 and 20 to 30%, respectively (Wentz, 1974; Kurman et al., 1985) . In our previous study, in endometrial hyperplasias, Cx26 showed weak or negative expression in 80.0% and Cx32 in 73.3% . It has been reported that in the case of the loss of expression or aberrant localization of Cxs, GJIC is suppressed (Yamasaki and Naus, 1996; Saito et al., 1998) and, in endometrial adenocarcinoma cells, reduced GJIC and expression of Cxs were well correlated in the present study. Therefore, it is likely that in most endometrial hyperplasia samples, GJIC was impaired under conditions in which ER was highly activated.
There are several lines of evidence suggesting that Cx expression is suppressed and/or aberrantly localized in precancerous lesions in several organs (Tsai et al., 1996; Krutovskikh and Yamasaki, 1997; Locke, 1998; Hanna et al., 1999; Laird et al., 1999) and many, if not all, tumor-promoting agents have been shown to inhibit GJIC of cultured cells as well as those in vivo , suggesting that the loss of GJIC enhances clonal dispersion, causing loss of the growth-suppression signals from the surrounding cells. For endometrial carcinogenesis, it may be concluded that the loss of GJIC caused by the suppressed expression and the aberrant localization of Cx support the clonal evolution of endometrial cancer cells originating in the hyperplasia cells. In the present study, GJIC of IK-ER1, which overexpresses ER-a, was markedly reduced in the estradiol-containing medium and the reduction was found to be inhibited by ICI182.780, a pure antiestrogen Figure 5 Western blotting of Cx26 and 32 with and without estradiol. IK-wild and IK-neo did not show clear changes in conditions of E(À), E( þ ) and ICI. On the other hand, in IK-ER1 E( þ ), the expression of Cx26 was decreased to 0.29 times that for E(À) condition. The expression of Cx32 in E( þ ) condition was also reduced 0.31 times of E(À). However, the reductions of expression in E( þ ) were inhibited by adding 10 À6 ICI182.780, both for Cx26 and Cx32 
